Cereius is developing innovative next-generation targeted radiotherapeutics for cancer patients.
Employees: 11-50
Total raised: $6.75M
Founded date: 2017
Investors 1
| Date | Name | Website |
| - | Mission Bi... | missionbio... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 26.07.2018 | - | $6.75M | BioInnovat... |
Mentions in press and media 5
| Date | Title | Description |
| 26.07.2018 | Biotechnology Company Cereius Raises $6.75M in Financing | Cereius, Inc., a Durham, NC-based biotechnology company developing novel approaches to treat solid tumor brain metastases, closed a $6.75m financing. The financing includes: – a $6.5M Series A round led by BioInnovation Capital, and include... |
| 25.07.2018 | BioInnovation Capital Leads $6.75M Financing for Cereius | Cereius, Inc., a biotechnology company developing novel approaches to treat solid tumor brain metastases, announced today that it has closed a $6.75 million financing. The financing includes a $6.5M Series A round led by BioInnovation Capit... |
| 25.07.2018 | BioInnovation Capital Leads $6.75M Financing for Cereius | Cereius, Inc., a biotechnology company developing novel approaches to treat solid tumor brain metastases, announced today that it has closed a $6.75 million financing. The financing includes a $6.5M Series A round led by BioInnovation Capit... |
| 25.07.2018 | Cereius Raises $6.75M | Cereius, Inc., a biotechnology company developing novel approaches to treat solid tumor brain metastases, announced today that it has closed a $6.75 million financing. The financing includes a $6.5M Series A round led by BioInnovation Capit... |
| 25.07.2018 | Cereius Raises $6.75M | Cereius, Inc., a biotechnology company developing novel approaches to treat solid tumor brain metastases, announced today that it has closed a $6.75 million financing. The financing includes a $6.5M Series A round led by BioInnovation Capit... |